Summary

The global market for Meglumine was estimated to be worth US$ 10.20 million in 2024 and is forecast to a readjusted size of US$ 14.19 million by 2031 with a CAGR of 4.1% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Meglumine cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Meglumine is a white crystalline powder. Melting point 128-129°C. Soluble in water, slightly soluble in ethanol, almost insoluble in chloroform. Taste sweet and salty astringent. The molecular formula is C7H17NO5 and the molecular weight is 195.21400. The density is 1.375, the melting point is 128-132ºC and the boiling point is 490.4ºC at 760 mmHg. Meglumine is an amino sugar derived from glucose.

In 2024, global Meglumine production reached approximately 352 MT, with an average global market price of around US$ 29 per KG.
The meglumine market is a niche segment within the pharmaceutical and medical chemical industry, primarily driven by its role as an excipient and stabilizing agent in the formulation of injectable drugs, contrast media, and other therapeutic solutions. Its demand is closely tied to the growth of the pharmaceutical sector, diagnostic imaging procedures, and the broader healthcare infrastructure. Increasing global healthcare spending, a rise in chronic disease prevalence, and expanding access to diagnostic services in emerging markets contribute to steady growth for meglumine. Additionally, regulatory emphasis on high-purity pharmaceutical ingredients has enhanced the importance of reliable supply and quality standards in this market.
From a competitive standpoint, the market is relatively consolidated, with production concentrated among a limited number of specialized chemical manufacturers. Pricing dynamics are influenced by raw material costs and the stringent compliance requirements for pharmaceutical-grade compounds. Growth opportunities are seen in Asia-Pacific, where expanding pharmaceutical manufacturing capacity and rising demand for contrast media in medical imaging are boosting consumption. However, market expansion may face challenges from substitution by alternative excipients, fluctuating supply chains, and compliance hurdles for manufacturers seeking entry into regulated markets such as the U.S. and Europe.

This report aims to provide a comprehensive presentation of the global market for Meglumine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Meglumine by region & country, by Type, and by Application.
The Meglumine market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meglumine.

Market Segmentation
By Company
Merck
Tianma
Libang Healthcare Group
New Hualian Pharm
Segment by Type
Diatrizoate Meglumine
Lothalamate Meglumine
Lodipamide Meglumine
Segment by Application
Cosolvent
Contrast agent
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Meglumine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Meglumine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Meglumine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Meglumine Product Introduction
1.2 Global Meglumine Market Size Forecast
1.2.1 Global Meglumine Sales Value (2020-2031)
1.2.2 Global Meglumine Sales Volume (2020-2031)
1.2.3 Global Meglumine Sales Price (2020-2031)
1.3 Meglumine Market Trends & Drivers
1.3.1 Meglumine Industry Trends
1.3.2 Meglumine Market Drivers & Opportunity
1.3.3 Meglumine Market Challenges
1.3.4 Meglumine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Meglumine Players Revenue Ranking (2024)
2.2 Global Meglumine Revenue by Company (2020-2025)
2.3 Global Meglumine Players Sales Volume Ranking (2024)
2.4 Global Meglumine Sales Volume by Company Players (2020-2025)
2.5 Global Meglumine Average Price by Company (2020-2025)
2.6 Key Manufacturers Meglumine Manufacturing Base and Headquarters
2.7 Key Manufacturers Meglumine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Meglumine
2.9 Meglumine Market Competitive Analysis
2.9.1 Meglumine Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Meglumine Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meglumine as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Diatrizoate Meglumine
3.1.2 Lothalamate Meglumine
3.1.3 Lodipamide Meglumine
3.2 Global Meglumine Sales Value by Type
3.2.1 Global Meglumine Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Meglumine Sales Value, by Type (2020-2031)
3.2.3 Global Meglumine Sales Value, by Type (%) (2020-2031)
3.3 Global Meglumine Sales Volume by Type
3.3.1 Global Meglumine Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Meglumine Sales Volume, by Type (2020-2031)
3.3.3 Global Meglumine Sales Volume, by Type (%) (2020-2031)
3.4 Global Meglumine Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cosolvent
4.1.2 Contrast agent
4.1.3 Other
4.2 Global Meglumine Sales Value by Application
4.2.1 Global Meglumine Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Meglumine Sales Value, by Application (2020-2031)
4.2.3 Global Meglumine Sales Value, by Application (%) (2020-2031)
4.3 Global Meglumine Sales Volume by Application
4.3.1 Global Meglumine Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Meglumine Sales Volume, by Application (2020-2031)
4.3.3 Global Meglumine Sales Volume, by Application (%) (2020-2031)
4.4 Global Meglumine Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Meglumine Sales Value by Region
5.1.1 Global Meglumine Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Meglumine Sales Value by Region (2020-2025)
5.1.3 Global Meglumine Sales Value by Region (2026-2031)
5.1.4 Global Meglumine Sales Value by Region (%), (2020-2031)
5.2 Global Meglumine Sales Volume by Region
5.2.1 Global Meglumine Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Meglumine Sales Volume by Region (2020-2025)
5.2.3 Global Meglumine Sales Volume by Region (2026-2031)
5.2.4 Global Meglumine Sales Volume by Region (%), (2020-2031)
5.3 Global Meglumine Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Meglumine Sales Value, 2020-2031
5.4.2 North America Meglumine Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Meglumine Sales Value, 2020-2031
5.5.2 Europe Meglumine Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Meglumine Sales Value, 2020-2031
5.6.2 Asia Pacific Meglumine Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Meglumine Sales Value, 2020-2031
5.7.2 South America Meglumine Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Meglumine Sales Value, 2020-2031
5.8.2 Middle East & Africa Meglumine Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Meglumine Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Meglumine Sales Value and Sales Volume
6.2.1 Key Countries/Regions Meglumine Sales Value, 2020-2031
6.2.2 Key Countries/Regions Meglumine Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Meglumine Sales Value, 2020-2031
6.3.2 United States Meglumine Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Meglumine Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Meglumine Sales Value, 2020-2031
6.4.2 Europe Meglumine Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Meglumine Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Meglumine Sales Value, 2020-2031
6.5.2 China Meglumine Sales Value by Type (%), 2024 VS 2031
6.5.3 China Meglumine Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Meglumine Sales Value, 2020-2031
6.6.2 Japan Meglumine Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Meglumine Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Meglumine Sales Value, 2020-2031
6.7.2 South Korea Meglumine Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Meglumine Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Meglumine Sales Value, 2020-2031
6.8.2 Southeast Asia Meglumine Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Meglumine Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Meglumine Sales Value, 2020-2031
6.9.2 India Meglumine Sales Value by Type (%), 2024 VS 2031
6.9.3 India Meglumine Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Introduction and Business Overview
7.1.3 Merck Meglumine Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Merck Meglumine Product Offerings
7.1.5 Merck Recent Development
7.2 Tianma
7.2.1 Tianma Company Information
7.2.2 Tianma Introduction and Business Overview
7.2.3 Tianma Meglumine Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Tianma Meglumine Product Offerings
7.2.5 Tianma Recent Development
7.3 Libang Healthcare Group
7.3.1 Libang Healthcare Group Company Information
7.3.2 Libang Healthcare Group Introduction and Business Overview
7.3.3 Libang Healthcare Group Meglumine Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Libang Healthcare Group Meglumine Product Offerings
7.3.5 Libang Healthcare Group Recent Development
7.4 New Hualian Pharm
7.4.1 New Hualian Pharm Company Information
7.4.2 New Hualian Pharm Introduction and Business Overview
7.4.3 New Hualian Pharm Meglumine Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 New Hualian Pharm Meglumine Product Offerings
7.4.5 New Hualian Pharm Recent Development
8 Industry Chain Analysis
8.1 Meglumine Industrial Chain
8.2 Meglumine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Meglumine Sales Model
8.5.2 Sales Channel
8.5.3 Meglumine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer